Abstract
A total of 74 COVID-19 diabetic patients were enrolled in the study. Twenty-seven patients (36.5%) were severely ill, and ten patients (13.5%) died. Severe patients had higher blood glucose, serum amyloid A (SAA), C reactive protein, and interleukin 6 levels than non-severe patients (P> 0.05). Severe patients had lower levels of albumin, cholesterol, high density lipoprotein, small and dense low density lipoprotein, and CD4 T lymphocyte counts than non-severe patients (P > 0.05). Reduced CD4 21 + T lymphocyte counts (OR = 0.988, 95 percent confidence interval [95 percent CI] 0.979–0.997) and elevated SAA levels (OR = 1.029, 95 percent CI 1.002–1.058) were found as risk variables for COVID- 19 severity with diabetes in a logistic regression analysis (P > 0.05).
 Keywords: COVID-19, Diabetes, Hyperglycemia, Dislipidemia, CD4+ T lymphocyte , follow up symptoms.
Highlights
Type 2 diabetes is a chronic condition that develops when the pancreas is unable to produce enough insulin or when the body's tissues are unable to adequately utilize insulin
This study looked at the clinical characteristics of COVID-19 patients with type 2 diabetes who were hospitalized at Zhongnan Hospital of Wuhan University in Wuhan, China, and looked at risk variables linked to COVID-19 severity in diabetics
According to the previous research, the 99 patients of COVID-19 admitted to Jinyintan Hospital in Wuhan 9 were mostly male (68.0 percent), with a median age of 55.5 years, a 23 percent ICU requirement, and an 11 percent fatality rate
Summary
Type 2 diabetes is a chronic condition that develops when the pancreas is unable to produce enough insulin or when the body's tissues are unable to adequately utilize insulin. Insulin is a hormone that aids the utilization of sugar (glucose) for energy by the body's cells. It aids in the storage of excess sugar in the body's muscle, fat, and liver cells [1]. China has diagnosed 84,250 cases in total, including 4642 deaths. Pneumonia, caused by a variety of infections, has become an increasingly common cause of death in diabetics. Clinical aspects of COVID-19 in diabetics, severe cases, have sparked widespread concern [3]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
